ANAB vs KMI · rev $234.6M vs P/E 24, rev $9.30B
AnaptysBio Inc (ANAB) versus Kinder Morgan Inc (KMI) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Kinder Morgan Inc (KMI) is a oil & gas midstream company listed on US.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. Revenue was up 157.0% from 2024-12-31 to 2025-12-31. ANAB currently screens at market cap $1.62B.
Latest reported KMI revenue for 2026-06-30 was $9.30B. Net income was $1.84B. Revenue was up 92.7% from 2026-03-31 to 2026-06-30. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
ANAB currently screens at market cap $1.62B. KMI currently screens at market cap $62.53B and trailing P/E 24.2.
Not investment advice. Open the ANAB and KMI stock pages for the full models.
Not investment advice.